Karen King is head of growth & development at CMC Affinity, a leading global medical communications agency and a division of McCann Health Medical Communications. Karen holds a Ph.D. in immuno-oncology from the Paterson Institute of Cancer Research, University of Manchester, U.K. She started out in academic research at the University of Oxford, before transitioning to CMC where she has worked for 20 years leading medical communications across a wide variety of therapy areas and products.